HPGD and cholangiocarcinoma: Additionally, Yao L et al. [113] reported that ω-3 PUFAs reduced miR26a/b expression through the negative regulation of the transcription factor c-myc, targeted enhancement of 15-PGDH activity, and downregulation of PGE2 expression, ultimately halting the progression of CCA.